Bioventix Statistics
Total Valuation
Bioventix has a market cap or net worth of GBP 107.11 million. The enterprise value is 102.03 million.
| Market Cap | 107.11M |
| Enterprise Value | 102.03M |
Important Dates
The last earnings date was Monday, October 27, 2025.
| Earnings Date | Oct 27, 2025 |
| Ex-Dividend Date | Nov 6, 2025 |
Share Statistics
Bioventix has 5.22 million shares outstanding. The number of shares has decreased by -0.08% in one year.
| Current Share Class | 5.22M |
| Shares Outstanding | 5.22M |
| Shares Change (YoY) | -0.08% |
| Shares Change (QoQ) | -0.15% |
| Owned by Insiders (%) | 6.07% |
| Owned by Institutions (%) | 68.30% |
| Float | 4.15M |
Valuation Ratios
The trailing PE ratio is 14.31 and the forward PE ratio is 15.06.
| PE Ratio | 14.31 |
| Forward PE | 15.06 |
| PS Ratio | 8.17 |
| PB Ratio | 9.27 |
| P/TBV Ratio | 9.27 |
| P/FCF Ratio | 15.27 |
| P/OCF Ratio | 15.23 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.04, with an EV/FCF ratio of 14.55.
| EV / Earnings | 13.45 |
| EV / Sales | 7.78 |
| EV / EBITDA | 10.04 |
| EV / EBIT | 10.13 |
| EV / FCF | 14.55 |
Financial Position
The company has a current ratio of 9.17
| Current Ratio | 9.17 |
| Quick Ratio | 4.68 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 64.40% and return on invested capital (ROIC) is 53.46%.
| Return on Equity (ROE) | 64.40% |
| Return on Assets (ROA) | 47.35% |
| Return on Invested Capital (ROIC) | 53.46% |
| Return on Capital Employed (ROCE) | 87.20% |
| Revenue Per Employee | 1.09M |
| Profits Per Employee | 632,037 |
| Employee Count | 12 |
| Asset Turnover | 0.99 |
| Inventory Turnover | 1.84 |
Taxes
In the past 12 months, Bioventix has paid 2.51 million in taxes.
| Income Tax | 2.51M |
| Effective Tax Rate | 24.88% |
Stock Price Statistics
The stock price has decreased by -39.71% in the last 52 weeks. The beta is 0.48, so Bioventix's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | -39.71% |
| 50-Day Moving Average | 2,387.50 |
| 200-Day Moving Average | 2,655.50 |
| Relative Strength Index (RSI) | 37.46 |
| Average Volume (20 Days) | 17,326 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioventix had revenue of GBP 13.12 million and earned 7.58 million in profits. Earnings per share was 1.43.
| Revenue | 13.12M |
| Gross Profit | 11.92M |
| Operating Income | 10.07M |
| Pretax Income | 10.10M |
| Net Income | 7.58M |
| EBITDA | 10.17M |
| EBIT | 10.07M |
| Earnings Per Share (EPS) | 1.43 |
Balance Sheet
The company has 5.08 million in cash and n/a in debt, giving a net cash position of 5.08 million or 0.97 per share.
| Cash & Cash Equivalents | 5.08M |
| Total Debt | n/a |
| Net Cash | 5.08M |
| Net Cash Per Share | 0.97 |
| Equity (Book Value) | 11.55M |
| Book Value Per Share | 2.21 |
| Working Capital | 10.72M |
Cash Flow
In the last 12 months, operating cash flow was 7.03 million and capital expenditures -19,189, giving a free cash flow of 7.01 million.
| Operating Cash Flow | 7.03M |
| Capital Expenditures | -19,189 |
| Free Cash Flow | 7.01M |
| FCF Per Share | 1.34 |
Margins
Gross margin is 90.86%, with operating and profit margins of 76.80% and 57.83%.
| Gross Margin | 90.86% |
| Operating Margin | 76.80% |
| Pretax Margin | 76.97% |
| Profit Margin | 57.83% |
| EBITDA Margin | 77.51% |
| EBIT Margin | 76.80% |
| FCF Margin | 53.47% |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 7.32%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 7.32% |
| Dividend Growth (YoY) | -3.23% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 108.05% |
| Buyback Yield | 0.08% |
| Shareholder Yield | 7.39% |
| Earnings Yield | 7.08% |
| FCF Yield | 6.55% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Bioventix has an Altman Z-Score of 86.73 and a Piotroski F-Score of 4.
| Altman Z-Score | 86.73 |
| Piotroski F-Score | 4 |